Home › Scleroderma › Alabama
Scleroderma clinical trials in Alabama
3 studies for Scleroderma are looking for participants at sites in Alabama.
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07497087Platform Clinical Study for Conquering Scleroderma
- University of Alabama - Division of Pulmonary and Critical Care Medicine, Birmingham
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Tuscaloosa, Tuscaloosa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.